|
Volumn 6, Issue 1, 2005, Pages 114-121
|
TAK-375 Takeda
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BROTIZOLAM;
DEXTROMETHORPHAN;
DIAZEPAM;
FLUCONAZOLE;
FLUOXETINE;
HYPNOTIC AGENT;
KETOCONAZOLE;
MELATONIN;
MELATONIN 1 RECEPTOR;
MELATONIN 1 RECEPTOR STIMULATING AGENT;
MELATONIN 2 RECEPTOR;
MIDAZOLAM;
PLACEBO;
RAMELTEON;
TRIAZOLAM;
UNCLASSIFIED DRUG;
ZOLPIDEM;
ZOPICLONE;
ABDOMINAL PAIN;
BINDING AFFINITY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONCENTRATION LOSS;
DIZZINESS;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG COMPETITION;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG EXPOSURE;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HEARTBURN;
HUMAN;
INSOMNIA;
MEMORY DISORDER;
NAUSEA;
NONHUMAN;
PRURITUS;
REVIEW;
SEDATION;
SIDE EFFECT;
SINGLE DRUG DOSE;
SOMNOLENCE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CLINICAL TRIALS;
HUMANS;
INDENES;
RECEPTOR, MELATONIN, MT1;
SLEEP DISORDERS;
|
EID: 12544258092
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (32)
|
References (0)
|